Essex Woodlands Management, Inc. Long-Term Concentrated

Location: The Woodlands, TX

CIK: 0001542339 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 10, 2016

Total Value: $547M (100.0% shares, 0.0% debt)

Holdings (9)

— ABIOMED INC 35.5%

Value $194M Shares 2,150,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 28.7%

Value $157M Shares 4,592,047 Est. Cost $31.50 Unrealized —

— CORIUM INTL INC 13.9%

Value $75.95M Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENTELLUS MED INC 11.8%

Value $64.29M Shares 3,813,197 Est. Cost $21.90 Unrealized —

AXGN AXOGEN INC 4.4%

Value $24.31M Shares 4,861,111 Est. Cost $4.01 Unrealized +23.4%

— ENDOLOGIX INC 3.4%

Value $18.48M Shares 1,257,468 Est. Cost $18.00 Unrealized —

ACUR ACURA PHARMACEUTICALS INC 0.9%

Value $4.891M Shares 1,956,397 Est. Cost $3.40 Unrealized -28.5%

MNOV MEDICINOVA INC 0.8%

Value $4.155M Shares 1,170,370 Est. Cost $2.95 Unrealized +7.7%

— CATALYST BIOSCIENCES INC 0.7%

Value $3.779M Shares 1,179,352 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	2,150,000	$194M	35.5%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$157M	28.7%	$31.50	—	COM	761330109
—	CORIUM INTL INC	9,353,304	$75.95M	13.9%	$7.77	—	COM	21887L107
—	ENTELLUS MED INC	3,813,197	$64.29M	11.8%	$21.90	—	COM	29363K105
AXGN	AXOGEN INC	4,861,111	$24.31M	4.4%	$4.01	+23.4%	COM	05463X106
—	ENDOLOGIX INC	1,257,468	$18.48M	3.4%	$18.00	—	COM	29266S106
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$4.891M	0.9%	$3.40	-28.5%	COM PAR $0.01	00509L802
MNOV	MEDICINOVA INC	1,170,370	$4.155M	0.8%	$2.95	+7.7%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	1,179,352	$3.779M	0.7%	$4.80	—	COM	14888D109